chr13-51958361-T-TG
Variant summary
The NM_000053.4(ATP7B):c.2304dupC (p.Met769HisfsTer26) variant causes a frameshift change. The variant is predicted to lead to nonsense-mediated mRNA decay (NMD). The variant allele was found at a cumulative frequency of 0.0000979 (AC=158) in the gnomAD database across 1,614,022 control chromosomes (no homozygotes observed). The grpmax filtering allele frequency (95% CI) is 0.000112. Splicing prediction tools (SpliceAI) predict no significant impact on normal splicing. Variant has been reported in ClinVar as Pathogenic/Likely Pathogenic (★★). ClinVar reports functional evidence for this variant: "SCV000694419: One functional study showed more than 50% decrease in ATPase activity in lymphoblasts a WD homozygote patient (Shah_AJHG_1997)." and additional evidence is available in ClinVar.
Frequency
Consequence
NM_000053.4 frameshift
Scores
Clinical Significance
Conservation
Publications
- Wilson diseaseInheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Genomics England PanelApp, ClinGen, Orphanet, Natera, Labcorp Genetics (formerly Invitae)
Genome browser will be placed here
Classification according to ACMG Germline Pathogenicity v2019
Our verdict: Pathogenic. The variant received 18 points.
| Apply | Criterion Code & Title / Strength | Rationale / Clinical Context | |
|---|---|---|---|
| PVS1Null variant in LOF gene | Frameshift/stop-gained, NMD predicted, LoF disease mechanism — very strong (PVS1); Frameshift (exon 8 of 21) at amino acid 768 of 1465, predicted to trigger nonsense-mediated mRNA decay. Loss of function is a known disease mechanism for this gene. A new stop codon is introduced in the shifted frame, truncating the protein to ~793 amino acids (672 amino acids lost). | ||
| PS3Functional studies show damaging effect | Well-established functional study supports damaging effect (PS3); SCV000694419: One functional study showed more than 50% decrease in ATPase activity in lymphoblasts a WD homozygote patient (Shah_AJHG_1997).; SCV004845542: "Lymphoblast cells derived from an individual homozygous for this variant showed loss of copper-stimulated ATPase activity (PMID: 9311736)."; SCV005061166: An experimental study showed this variant caused a more than 50% decrease in ATPase activity in lymphoblasts in a homozygote patient affected with Wilson disease (Shah et al., 1997). | ||
| PM2Absent/extremely low in population databases | Very rare in gnomAD for AR/unknown gene (popmax AF < threshold/10) — PM2; GnomAD popmax AF = 0.000112 — very rare for AR gene (base 0.001, raised to 0.00322 by highest known P/LP ClinVar AF 0.00322) — PM2 moderate. | ||
| PP5Reputable source reports pathogenic | ClinVar 2-star pathogenic — strong (PP5); ClinVar submissions overwhelmingly pathogenic (≥10 total, ≥80% P/LP, <10% B/LB) — strong (PP5, count-based); ClinVar germline classification: Pathogenic/Likely Pathogenic, 2 star(s). ClinVar submissions strongly and reliably favor pathogenicity (29/29 total P/LP). |
Variant Effect in Transcripts
Automated classification analysis was done for transcript: NM_000053.4. You can select a different transcript below to see updated classification assignments.
RefSeq Transcripts
| Sel. | Gene / Transcript | Tags | HGVSc / HGVSp | Effect | Exon rank | Protein / UniProt |
|---|---|---|---|---|---|---|
ATP7B | MANE Select | c.2304dupC p.Met769HisfsTer26 | frameshift | Exon 8 of 21 | Prot: NP_000044.2 UniProt: | |
ATP7B | c.2304dupC p.Met769HisfsTer26 | frameshift | Exon 9 of 22 | Prot: NP_001393440.1 UniProt: | ||
ATP7B | c.2304dupC p.Met769HisfsTer26 | frameshift | Exon 9 of 22 | Prot: NP_001393441.1 UniProt: |
Ensembl Transcripts
| Sel. | Gene / Transcript | Tags | HGVSc / HGVSp | Effect | Exon rank | Protein / UniProt |
|---|---|---|---|---|---|---|
ATP7B | TSL:1MANE Select | c.2304dupC p.Met769HisfsTer26 | frameshift | Exon 8 of 21 | Prot: ENSP00000242839.5 UniProt: | |
ATP7B | TSL:1 | c.2160dupC p.Met721HisfsTer26 | frameshift | Exon 8 of 21 | Prot: ENSP00000489398.1 UniProt: | |
ATP7B | TSL:1 | c.2304dupC p.Met769HisfsTer26 | frameshift | Exon 8 of 20 | Prot: ENSP00000393343.2 UniProt: |
Frequencies
Allele frequencies (AF), counts (AC/AN), homozygotes and coverage
| Source / population | AF | AC | Hom | AN | Coverage |
|---|---|---|---|---|---|
Global population databases 6 sources | |||||
GnomAD3 genomes | AF: 0.000118 | AC:18 | Hom:0 | AN:152130 | Cov:32 |
GnomAD2 exomes | AF: 0.000108 | AC:27 | AN:249552 | ||
GnomAD4 exome | AF: 0.0000958 | AC:140 | Hom:0 | AN:1461892 | Cov:31 |
GnomAD4 genome | AF: 0.000118 | AC:18 | Hom:0 | AN:152130 | Cov:32 |
TOPMed (Bravo) | AF: 0.0000945 | AC:25 | Hom:0 | AN:264690 | |
ALFA (dbGaP/dbSNP Allele Frequency Aggregator) | AF: 0.0000990 | AC:3 | Hom:0 | AN:30296 | |
Local & regional cohorts 3 sources | |||||
ToMMo 61KJPN (+60KJPN MNV) | AF: 0.0000490 | AC:6 | Hom:0 | AN:122696 | |
Turkish Variome | AF: 0.000708 | AC:4 | Hom:0 | AN:5176 | |
WBBC (Westlake BioBank for Chinese) pilot | AF: 0.00 | AC:0 | Hom:0 | AN:8960 | |
Case/control cohorts
| Cohort | Cases | Controls | ||||
|---|---|---|---|---|---|---|
| AF | AC | AN | AF | AC | AN | |
ASC | 0.000104 * | 1 | 9622 | 0.0000959 * | 1 | 10428 |
BipEx | 0.000106 | 3 | 28420 | 0.0000693 | 2 | 28844 |
Epi25 | 0.0000953 | 4 | 41958 | 0.000105 | 7 | 66888 |
SCHEMA | 0.000205 | 25 | 121906 | 0.000110 | 21 | 190632 |
ClinVar
Computational Scores
| Algorithm | Calibrated pred. | Score | Prediction |
|---|---|---|---|
Mutation Taster | N/A | 0/200 | disease causing (ClinVar) |
PhyloP100 | Benign | -2.2 |
Splicing Scores
| Algorithm | Calibrated pred. | Score | Prediction |
|---|---|---|---|
SpliceAI score (max) | Benign | 0.020 | Details are displayed if max score is > 0.2 |
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
MaxEntScan Visualizer can be used to analyze the impact of this mutation on the neighboring sequence.